Novo Nordisk has invested €432m ($501m) to upgrade its facility in Ireland to ensure the drugmaker can meet the anticipated high...
Following Eli Lilly's disappointing earnings showing last week, Novo Nordisk’s latest report on the performance of its GLP-1 sta...